Bausch Health Companies (NYSE:BHC) Shareholders Are up 7.0% This Past Week, but Still in the Red Over the Last Five Years
Bausch Health Companies (NYSE:BHC) Shareholders Are up 7.0% This Past Week, but Still in the Red Over the Last Five Years
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held Bausch Health Companies Inc. (NYSE:BHC) for five whole years - as the share price tanked 72%. On the other hand the share price has bounced 7.0% over the last week.
長期投資效果很好,但並不總是適用於每隻個股。當我們看到其他投資者遭受損失時,心裏總是很不舒服。想想那些在五年前就持有Bausch Health Companies Inc.(紐交所:BHC)的人——他們的股價已經暴跌了72%。另一方面,過去一週股價反彈了7.0%。
While the stock has risen 7.0% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.
雖然股票在過去一週上漲了7.0%,但長期股東仍然處於虧損狀態,我們來看看基本面能告訴我們什麼。
Bausch Health Companies wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.
Bausch Health Companies在過去十二個月裏並未盈利,因此其股價與每股收益(EPS)之間幾乎沒有強相關性。可以說,營業收入是我們的下一個最佳選擇。一般來說,未盈利的公司預計每年營業收入都會增長,而且增幅相當可觀。這是因爲如果營業收入增長微乎其微,公司是否能夠持續經營就令人難以確信,並且它從未盈利。
Over five years, Bausch Health Companies grew its revenue at 1.6% per year. That's not a very high growth rate considering it doesn't make profits. It's not so sure that share price crash of 11% per year is completely deserved, but the market is doubtless disappointed. We'd be pretty cautious about this one, although the sell-off may be too severe. A company like this generally needs to produce profits before it can find favour with new investors.
在五年內,Bausch Health Companies的營業收入年均增長1.6%。考慮到它沒有盈利,這個增長率並不高。股價每年下跌11%是否完全合理還有待確認,但市場顯然感到失望。我們對此持謹慎態度,儘管拋售可能過於嚴重。像這樣的公司通常需要在找到新投資者之前產生利潤。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
您可以在下面的圖像中查看收益和營業收入隨時間的變化(點擊圖表查看確切值)。
Take a more thorough look at Bausch Health Companies' financial health with this free report on its balance sheet.
通過這份關於Bausch Health公司的資產負債表的免費報告,深入了解該公司的財務狀況。
A Different Perspective
不同的視角
Bausch Health Companies shareholders gained a total return of 3.6% during the year. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 11% endured over half a decade. So this might be a sign the business has turned its fortunes around. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for Bausch Health Companies that you should be aware of.
Bausch Health公司的股東在過去一年獲得了3.6%的總回報。但這低於市場平均水平。值得高興的是,這仍然是一個增益,當然比過去五年約11%的年度損失要好。因此,這可能是公司扭轉了運勢的跡象。雖然考慮市場狀況對股價的不同影響非常重要,但還有其他因素更加重要。例如,我們識別出Bausch Health公司有1個警告信號需要引起注意。
Of course Bausch Health Companies may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
當然,Bausch Health公司可能不是最值得買入的股票。因此,您可能希望查看這份免費的增長股票集合。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。